Company Name, Ticker, Customers, else..

Valuation Comparisons

Management Effectiveness

• ROA Quarterly

• ROI Quarterly

• ROE Quarterly

Financial Strength

Dividend Comparisons

Syros Pharmaceuticals Inc (SYRS)

Other Ticker:

Sector • Healthcare Industry • Major Pharmaceutical Preparations

Industry • Major Pharmaceutical Preparations

Sector • Healthcare

Syros Pharmaceuticals Inc 's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics

Select the Comparisons :

None ▼

Select the Ratio:

Return on Equity ROE▼

None ▼

Return on Equity ROE▼

Return On Equity	(Dec 31 2022) IV. Quarter	(Sep 30 2022) III. Quarter	(Jun 30 2022) II. Quarter	(Mar 31 2022) I. Quarter	(Dec 31 2021) IV. Quarter
Y / Y Equity Change	49.89 %	21.79 %	-76.14 %	-58.14 %	-
Y / Y Net Income Change	-	-	-	-	-
Net Income (TTM) in Millions	-95	-114	-109	-97	-87
Return On Equity (TTM)	-107.97 %	-147.58 %	-153.62 %	-101.54 %	-73.49 %
Total Ranking	#	#	#	#	#
Equity (TTM) in Millions	128	129	31	63	85
Seq. Equity Change	-1.11 %	316.43 %	-50.56 %	-26.37 %	-19.65 %
Seq. Net Income Change	-	-	-	-	-

Back to SYRS Management Effectiveness >> SYRS's 5 Years Annual ROE >> Compare SYRS ROE to its Competitors

Roe Comment

Within Healthcare sector Syros Pharmaceuticals Inc achieved highest return on equity. While total ranking remained unchanged compare to previous quarter at no. .

What is ROE?

Return On Equity Company Ranking
Within:	No.
Industry	#
Sector	#
Overall	#

Return On Equity Statistics
High	Average	Low
0 %	0 %	0 %

SYRS Annual Return On Equity	(Dec 31 2022) 2022	(Dec 31 2021) 2021	(Dec 31 2020) 2020	(Dec 31 2019) 2019	(Dec 31 2018) 2018
Total Equity in Millions	128	85	91	79	79
Y / Y Equity Change	49.89 %	-5.89 %	14.36 %	0.76 %	20.3 %
Net Income in Millions	-95	-87	-84	-75	-62
Y / Y Net Income Change	-	-	-	-	-
Return On Equity	-74.1 %	-101.57 %	-92.81 %	-95.27 %	-79.25 %

Back to SYRS Management Effectiveness >> SYRS's 5 Years Annual ROE >> Compare SYRS ROE to its Competitors

Financial Statements
Syros Pharmaceuticals Inc 's Equity	$ 128 Millions	SYRS's Balance sheet
Syros Pharmaceuticals Inc 's Income	$ -5 Millions	Quarterly SYRS's Income Statement
SYRS's Income by Division		See SYRS's Income by Division

More Return On Equity Ratios
Major Pharmaceutical Preparations Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
Roe Trends for overall market
SYRS's Roe Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Roe for SYRS's Competitors
Return On Equity for Syros Pharmaceuticals Inc 's Suppliers
Roe for SYRS's Customers

You may also want to know
SYRS's Roa	SYRS's Inventory Turnover Ratio	SYRS's Growth Rates	SYRS's Dividend Statistics
	SYRS's Profitability Ratios	SYRS's Asset Turnover Ratio	SYRS's Dividend Growth
SYRS's Roi	SYRS's Valuation Ratios	SYRS's Financial Strength Ratios	SYRS's Dividend Payout Ratio

Companies with similar Return On Equity at Dec 31 2022, within Healthcare Sector

ROE

Date modified: 2023-03-03T14:50:46+00:00


Economy Advance Monthly Sales Consumer Price Index CPI Producer Price Index PPI Retail Inventories Personal Income Gross Domestic Product GDP Money Supply Industrial Production Productivity Employment Situation US International Trade Factory Orders Durable Goods Construction Spending Housing Starts Vehicle Unit Sales	Stocks Event Calendar IPSC's Profile Stock Price IPSC's Financials Business Description Fundamentals Charts & Quotes IPSC's News Suppliers IPSC's Competitors Customers & Markets Economic Indicators IPSC's Growth Company Segments	Screening Stock Performance Growth Rates Profitability Valuation Dividend Financial Strength Efficiency Largest Companies Management Effectivness

Help

Sitemap

Advertise

About us

Glossary

Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071